Today’s most urgent problem in transplantation is the lack of suitable donor organs and tissues and as the population ages, demands for organs and tissue therapies will only increase. One alternative to organ transplantation is cell therapy whose aim is to replace, repair or enhance the biological function of damaged tissue or diseased organs. One goal of cellular transplantation thus has been to find a renewable source of cells that could be used in humans. Embryonic stem (ES) cells have the potential to proliferate in vitro in an undifferentiated and pluripotent state. Theoretically, ES cells are capable of unlimited proliferation in vitro. ES cells spontaneously differentiate into derivatives of all three primary germ layers: endoderm, ectoderm and mesoderm, hence providing cells in vitro which can theoretically be isolated and used for transplantation. Furthermore, these pluripotent stem cells can potentially be used to produce large numbers of cells that can be genetically modified in vitro. Once available, this source of cells may obviate some of the critical needs for organ transplantation. Murine ES cells have been extensively studied and all available evidence indicates that all aforementioned expectations are indeed fulfilled by ES cells. ES cells as well as embryonic germ cells have recently been isolated and maintained in culture. The recent descriptions of human ES cells portend the eventual use of allogeneic in vitro differentiated cells for human therapy. This goal, however, is fraught with obstacles. Our aim is first to review the recent advances made with murine ES cells and then to point out potentials and difficulties associated with the use of human ES cells for transplantation.

Keywords:
Embryonic stem cells, Cell replacement therapy
1.
Bianco, P., S.A. Kuznetsov, M. Riminucci, L.W. Fisher, A.M. Spiegel, P.G. Robey (1998) Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsa-mutated skeletal progenitor cells. J Clin Invest 101: 1737–1744.
2.
Braun, T., H.-H. Arnold (1996) Myf5 and myoD are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineage. EMBO J 15: 310–318.
3.
Choi, K., M. Kennedy, A. Kazarov, J.C. Papadimitriou, G. Keller (1998) A common precursor for hematopoietic and endothelial cells. Development 125: 725–732.
4.
Dekel, L., Y. Magal, S. Pearson-White, C.P. Emerson, M. Shani (1992) Conditional conversion of ES cells to skeletal muscle by an exogenous myoD1 gene. New Biol 4: 217–224.
5.
Dani, C. (1999) Embryonic stem cell-derived adipogenesis. Cells Tissues Organs 165: 173–180.
6.
Dinsmore, J., J. Ratliff, T. Deacon, P. Pakzaban, V. Jacoby, W. Galpern, V. Isacson (1996) Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant 5: 131–143.
7.
Doetschman, T., P. Williams, N. Maeda (1988) Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev Biol 127: 224–227.
8.
Doetschman, T.C., H. Eistetter, M. Katz, W. Schmidt, R. Kemler (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27–45.
9.
Drab, M., H. Haller, R. Bychkov, B. Erdmann, C. Lindschau, H. Haase, I. Morano, F.C. Luft, A.M. Wobus (1997) From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: A retinoic acid and db-cAMP in vitro differentiation model. FASEB J 11: 905–915.
10.
Evans, M.J., M.H. Kaufman (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154–156.
11.
Gage, F.H. (1998) Cell therapy. Nature 392: 18–24.
12.
Geisterfer-Lowrance, A.A.T., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, J.G. Seidman (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731–734.
13.
Gossen, M., H. Bujard (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547–5551.
14.
Gottlieb, D.I., J.E. Huettner (1999) An in vitro pathway from embryonic stem cells to neurons and glia. Cells Tissues Organs 165: 165–172.
15.
Greiner, D.L., R.A. Hesselton, L.D. Shultz (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16: 166–177.
16.
Grépin, C., G. Nemer, M. Nemer (1997) Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 124: 2387–2395.
17.
Hescheler, J., B.K. Fleischmann, S. Lentini, V.A. Maltsev, J. Rohwedel, A.M. Wobus, K. Addicks (1997) Embryonic stem cells: A model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 36: 149–162.
18.
Klug, M.G., M.H. Soonpaa, G.Y. Koh, L.J. Field (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98: 216–224.
19.
Koh, G.Y., M.G. Klug, M.H. Soonpaa, L.J. Field (1993) Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 92: 1548–1554.
20.
Koh, G.Y., M.H. Soonpaa, M.G. Klug, H.P. Pride, B.J. Cooper, D.P. Zipes, L.J. Field (1995) Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96: 2034–2042.
21.
Kolossov, E., B.K. Fleischmann, Q. Liu, W. Bloch, S. Viatchenko-Karpinski, O. Manzke, G.J. Li, H. Bohlen, K. Addicks, J. Hescheler (1998) Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 143: 2045–2056.
22.
Kuhn, R., F. Schwenk, M. Aguet, K. Rjewsky (1995) Inducible gene targeting in mice. Science 269: 1427–1429.
23.
Li, M., L. Pevny, R. Lovell-Badge, A. Smith (1998) Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 8: 971–974.
24.
Logie, C., A.F. Stewart (1995) Ligand-regulated site-specific recombination. Proc Natl Acad Sci USA 92: 5940–5944.
25.
Maltsev, V.A., A.M. Wobus, J. Rohwedel, M. Bader, J. Hescheler (1994) Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75: 233–244.
26.
Martin, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634–7638.
27.
Mayford, M., M.E. Bach, Y.-Y. Huang, L. Lang, R.D. Hawkins, E.R. Kandel (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274: 1678–1683.
28.
Pari, G., K. Jardine, M.W. McBurney (1991) Multiple CArG boxes in the human cardiac actin gene promoter required for expression in embryonic cardiac muscle cells developing in vitro from embryonal carcinoma cells. Mol Cell Biol 11: 4796–4803.
29.
Platt, J.L. (1998) New directions for organ transplantation. Nature 392: 11–17.
30.
Redfern, C.H., P. Coward, M.Y. Degtyarev, E.K. Lee, A.T. Kwa, L. Hennighausen, H. Bujard, G.I. Fishman, B.R. Conklin (1999) Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol 17: 165–169.
31.
Rohwedel, J., K. Guan, W. Zuschratter, S. Jin, G. Ahnert-Hilger, D. Fürst, R. Fässler, A.M. Wobus (1998) Loss of β1 integrin function results in a retardation of myogenic but an acceleration of neuronal differentiation of embryonic stem cells in vitro. Dev Biol 201: 167–184.
32.
Shamblott, M.J., J Axelman, S. Wang, E.M. Bugg, J.W. Littlefield, P.J. Donovan, P.D. Blumenthal, G.R. Huggins, J.D. Gearhart (1998) Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 95: 13726–13731.
33.
Smith, A.J.H., M.A.D. Sousa, B. Kwabi-Addo, A. Heppell-Parton, H. Impey, P. Rabbitts (1995) A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet 9: 376–385.
34.
Stanford, W.L., G. Caruana, K.A. Vallis, M. Inamdar, M. Hidaka, V.O. Bautch, A. Bernstein (1998) Expression trapping: Identification of novel genes expressed in hematopoietic and endothelial lineages by gene trapping in ES cells. Blood 92: 4622–4631.
35.
Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, J.M. Jones (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
36.
Tsien J.Z., D.F. Chen, D. Gerber, C. Tom, E.H. Mercer, D.J. Anderson, M. Mayford, E.R. Kandel, S. Tonegawa (1996) Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87: 1317–1326.
37.
Van Deursen, J., M. Fornerod, B. Van Rees, G. Grosveld (1995) Cre-mediated site-specific translocation between nonhomologous mouse chromosome. Proc Natl Acad Sci USA 92: 7375–7380.
38.
Wiles, M.V., G. Keller (1991) Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111: 259–267.
39.
Williams, R.L., D.J. Hilton, S. Pease, T.A. Willson, C.L. Stewart, D.P. Gearing, E.F. Wagner, D. Metcalf, N.A. Nicola, N.M. Gough (1988) Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687.
40.
Wobus, A.M., K. Guan (1998) Embryonic stem cell-derived cardiac differentiation: Modulation of differentiation and ‘loss-of-function’ analysis in vitro. Trends Cardiovasc Med 8: 64–74.
41.
Wobus, A.M., H. Holzhausen, P. Jäkel, J. Schöneich (1984) Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp Cell Res 152: 212–219.
42.
Wobus, A.M., G. Wallukat, J. Hescheler (1991) Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 48: 173–182.
43.
Young, L.E., K.D. Sinclair, I. Vilmut (1998) Large offspring syndrome in cattle and sheep. Rev Reprod 3: 155–163.
44.
Yu, Z., C.S. Redfern, G.I. Fishman (1996) Conditional transgene expression in the heart. Circ Res 79: 691–697.
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.